Clearmind Medicine Inc. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K report covers the month of February 2026 for Clearmind Medicine Inc., a foreign private issuer. The filing details the execution of a securities purchase agreement entered into on September 17, 2025, regarding the issuance of convertible promissory notes.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, or cash flow data. The specific financial activity reported is the closing of a debt financing tranche:
- Tranche 1 Closing Date: February 4, 2026
- Principal Amount Issued: $600,000
- Cash Proceeds Received: $540,000 (90% of principal)
- Total Facility Size: Up to $10,000,000 principal
- Remaining Notice Amount: $1,900,000 principal (Tranche 2)
Material Changes
The Company delivered a notice to investors to issue $2,500,000 in aggregate principal amount of Promissory Notes. The first tranche of $600,000 principal was successfully closed on February 4, 2026. The second tranche of $1,900,000 principal is contingent upon the filing of a registration statement covering the resale of common shares issuable upon conversion.
Outlook, Risks, and Contingencies
The closing of the second tranche is contingent on regulatory filings. The Company must file a registration statement with the SEC covering the resale of common shares issuable upon conversion of the notes from both tranches. The notes are convertible into common shares. No specific risks or unusual items beyond the standard terms of the convertible note agreement are detailed in this text.
Investor Verification Checklist
- Verify the status of the registration statement required to close the second tranche of $1,900,000.
- Confirm the conversion terms and interest rates of the Promissory Notes in the original September 17, 2025, SPA.
- Review the Company's cash position to assess the impact of the $540,000 proceeds on liquidity.
- Check for any subsequent filings regarding the full $2,500,000 notice or the remaining $7,500,000 capacity under the facility.